In October 2007 data was presented at the European Congress of MS in Prague regarding safety findings of a pilot study of low dose naltrexone therapy in multiple sclerosis by neurological researchers in Milan, Italy.
Oktobra 2007 podaci su prezentirani na Evropskom Kongresu za MS u Pragu, u pogledu bezbednosnih nalaza pilot studije niske doze naltrekson kod pacijenata od multiple skleroze od strane neuroloških istraživača u Milanu, Italija.